Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th
WARRINGTON, Pa. , Oct. 03, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser , President and Chief Executive
Article Date
October 3, 2023
This article is featured on another website.
Go to article
July 10, 2026
Sarcoma Clinical Trials – Cell Therapy’s Solid-Tumor Breakthrough, and What It Means for a Rare Cancer
A Turning Point for Cell Therapy in Solid Tumors, and for Sarcoma For most of…
July 10, 2026
Sarcoma Clinical Trials – Cell Therapy’s Solid-Tumor Breakthrough, and What It Means for a Rare Cancer
A Turning Point for Cell Therapy in Solid Tumors, and for Sarcoma For most of…
April 23, 2026
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…
April 23, 2026
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…